These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

876 related items for PubMed ID: 21663387

  • 21. Immunoglobulin A nephropathy and chronic kidney disease.
    Tomino Y.
    Nephrology (Carlton); 2010 Jun; 15 Suppl 2():23-6. PubMed ID: 20586943
    [Abstract] [Full Text] [Related]

  • 22. [Clinical evaluation of tonsillectomy with modified high-dose intravenous methylprednisolone therapy in patients with IgA nephropathy].
    Sugawara K, Takeda K, Nakai K, Takahashi N, Adachi T, Fukuda T, Miura S.
    Nihon Jinzo Gakkai Shi; 2008 Jun; 50(8):1017-23. PubMed ID: 19172803
    [Abstract] [Full Text] [Related]

  • 23. Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapy.
    Maeda I, Hayashi T, Sato KK, Shibata MO, Hamada M, Kishida M, Kitabayashi C, Morikawa T, Okada N, Okumura M, Konishi M, Konishi Y, Endo G, Imanishi M.
    Nephrol Dial Transplant; 2012 Jul; 27(7):2806-13. PubMed ID: 22492824
    [Abstract] [Full Text] [Related]

  • 24. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
    Tang Z, Ji SM, Chen DR, Wen JQ, Chen JS, Liu ZH, Li LS.
    Ren Fail; 2008 Jul; 30(6):611-6. PubMed ID: 18661411
    [Abstract] [Full Text] [Related]

  • 25. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
    Komatsu H, Fujimoto S, Sato Y, Hara S, Yamada K, Morita S, Eto T.
    J Nephrol; 2005 Jul; 18(6):690-5. PubMed ID: 16358226
    [Abstract] [Full Text] [Related]

  • 26. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
    Bazzi C, Rizza V, Paparella M, Casellato D, Napodano P, Olivieri G, D'Amico G.
    J Nephrol; 2009 Jul; 22(3):387-96. PubMed ID: 19557716
    [Abstract] [Full Text] [Related]

  • 27. IgA nephropathy: the presence of familial disease does not confer an increased risk for progression.
    Izzi C, Ravani P, Torres D, Prati E, Viola BF, Guerini S, Foramitti M, Frascà G, Amoroso A, Ghiggeri GM, Schena FP, Scolari F.
    Am J Kidney Dis; 2006 May; 47(5):761-9. PubMed ID: 16632014
    [Abstract] [Full Text] [Related]

  • 28. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
    Bazzi C, Rizza V, Casellato D, Stivali G, Rachele G, Napodano P, Olivieri G, Gallieni M, D'Amico G.
    J Nephrol; 2012 May; 25(5):810-8. PubMed ID: 22252844
    [Abstract] [Full Text] [Related]

  • 29. Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy.
    Lundberg S, Lundahl J, Gunnarsson I, Sundelin B, Jacobson SH.
    Nephrol Dial Transplant; 2012 May; 27(5):1916-23. PubMed ID: 21940483
    [Abstract] [Full Text] [Related]

  • 30. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system.
    Lee HS, Lee MS, Lee SM, Lee SY, Lee ES, Lee EY, Park SY, Han JS, Kim S, Lee JS.
    Nephrol Dial Transplant; 2005 Feb; 20(2):342-8. PubMed ID: 15618239
    [Abstract] [Full Text] [Related]

  • 31. Predictors for progression in immunoglobulin A nephropathy with significant proteinuria.
    Hwang HS, Kim BS, Shin YS, Yoon HE, Song JC, Choi BS, Park CW, Yang CW, Kim YS, Bang BK.
    Nephrology (Carlton); 2010 Mar; 15(2):236-41. PubMed ID: 20470285
    [Abstract] [Full Text] [Related]

  • 32. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
    Pozzi C, Del Vecchio L, Locatelli F.
    G Ital Nefrol; 2002 Mar; 19(5):523-8. PubMed ID: 12439840
    [Abstract] [Full Text] [Related]

  • 33. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
    Perkins RM, Aboudara MC, Uy AL, Olson SW, Cushner HM, Yuan CM.
    Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
    [Abstract] [Full Text] [Related]

  • 34. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
    Pozzi C, Andrulli S, Pani A, Scaini P, Roccatello D, Fogazzi G, Pecchini P, Rustichelli R, Finocchiaro P, Del Vecchio L, Locatelli F.
    J Nephrol; 2013 Apr; 26(1):86-93. PubMed ID: 22460183
    [Abstract] [Full Text] [Related]

  • 35. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
    Robles NR, Romero B, Fernandez-Carbonero E, Sánchez-Casado E, Cubero JJ.
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
    [Abstract] [Full Text] [Related]

  • 36. Presentation, prognosis and outcome of IgA nephropathy in Indian adults.
    Chacko B, John GT, Neelakantan N, Korula A, Balakrishnan N, Kirubakaran MG, Jacob CK.
    Nephrology (Carlton); 2005 Oct; 10(5):496-503. PubMed ID: 16221102
    [Abstract] [Full Text] [Related]

  • 37. Remission of proteinuria improves prognosis in IgA nephropathy.
    Reich HN, Troyanov S, Scholey JW, Cattran DC, Toronto Glomerulonephritis Registry.
    J Am Soc Nephrol; 2007 Dec; 18(12):3177-83. PubMed ID: 17978307
    [Abstract] [Full Text] [Related]

  • 38. Increased Serum IgA in Children with IgA Nephropathy, Severity of Kidney Biopsy Findings and Long-Term Outcomes.
    Mizerska-Wasiak M, Małdyk J, Pańczyk-Tomaszewska M, Turczyn A, Cichoń-Kawa K, Rybi-Szumińska A, Wasilewska A, Firszt-Adamczyk A, Stankiewicz R, Bieniaś B, Zajączkowska M, Gadomska-Prokop K, Grenda R, Miklaszewska M, Pietrzyk J, Pukajło-Marczyk, Zwolińska D, Szczepańska M, Demkow U, Roszkowska-Blaim M.
    Adv Exp Med Biol; 2015 Dec; 873():79-86. PubMed ID: 26269025
    [Abstract] [Full Text] [Related]

  • 39. [IgA nephropathy: from predicting progression to treatment].
    Rauta V, Grönhagen-Riska C.
    Duodecim; 2006 Dec; 122(2):215-22. PubMed ID: 16509071
    [No Abstract] [Full Text] [Related]

  • 40. Cigarette smoking and progression of IgA nephropathy.
    Yamamoto R, Nagasawa Y, Shoji T, Iwatani H, Hamano T, Kawada N, Inoue K, Uehata T, Kaneko T, Okada N, Moriyama T, Horio M, Yamauchi A, Tsubakihara Y, Imai E, Rakugi H, Isaka Y.
    Am J Kidney Dis; 2010 Aug; 56(2):313-24. PubMed ID: 20471735
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.